MESA LABORATORIES INC /CO/ MLAB
Nasdaq · XNAS · stock · Industrial Instruments For Measurement, Display, and Control
Chart by TradingView
8/9
Piotroski F — financial health
0.37
Altman Z″ — distress risk · distress
52.5%
Dividend payout · moderate
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $249.1M | $6.7M | $158.3M | $39.6M | $186.2M |
| 2025 | $241.0M | -$2.0M | $150.9M | $42.6M | $159.8M |
| 2024 | $216.2M | -$254.2M | $133.2M | $41.6M | $145.4M |
| 2023 | $219.1M | $930,000 | $133.7M | $23.4M | $393.5M |
| 2022 | $184.3M | $1.9M | $109.1M | $34.8M | $393.8M |
| 2021 | $133.9M | $3.3M | $87.0M | $35.1M | $406.2M |
Why these scores methodology →
Piotroski F-score: 8/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.37 (distress)
- Working capital / assets 0.104
- Retained earnings / assets -0.434
- EBIT / assets 0.043
- Equity / liabilities 0.771
Source: SEC EDGAR filings · CIK 0000724004 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.